|
In September 2005, the Centers for Medicare & Medicaid Services (CMS) contracted with BearingPoint to develop a set of candidate medication measures intended for use by QIOs and End Stage Renal Disease (ESRD) Networks to improve quality and patient safety in providing care to the Medicare-eligible population with chronic kidney disease (CKD) and ESRD. BearingPoint, and the TEP succeeded in developing an initial set of medication measures for the CKD and ESRD populations. Bearing Point developed draft technical specifications for the ESRD/CKD medication Measure Sets 1 and 2, in February and May 2007, respectively. Measure Set 1 included measures that could be calculated using Part D enrollment and drug claims data as well as data from the Renal Management Information System (REMIS)/Standard Information Management System (SIMS) to identify Part D enrollees with ESRD (dialysis) and CKD beneficiaries with a functioning transplant. Measure Set 2 included measures that required additional data.
Page Last Modified: 08/29/2008 3:00:00 PM
Help with File Formats and Plug-Ins
Submit Feedback
|
Email
Print